US Stock MarketDetailed Quotes

KRUS Kura Sushi USA

Watchlist
  • 62.200
  • -0.480-0.77%
Close Feb 28 16:00 ET
  • 62.200
  • 0.0000.00%
Post 20:01 ET
750.51MMarket Cap-90.14P/E (TTM)

Kura Sushi USA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kura Sushi USA Q1 2025 Earnings Date

Currency：USDJan 7, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
61.72M
64.46M
+2.74M
Beat Est.
+19.90%
+25.22%
+4.43%
EPS
-0.21
-0.08
+0.13
Beat Est.
-14.45%
+55.56%
+61.15%
Analyst Rating
Buy

Feb 28, 2025

Kura Sushi USA Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 72.942M--
--2025/Q2-- / 66.300M--
Jan 7, 20252025/Q164.456M / 61.721M--
Nov 6, 20242024/Q466.012M / 64.021M--
Jul 9, 20242024/Q363.082M / 63.103M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 72.942M--
--2025/Q2-- / 66.300M--
Jan 7, 20252025/Q164.456M / 61.721M--
Nov 6, 20242024/Q466.012M / 64.021M--
Jul 9, 20242024/Q363.082M / 63.103M--

Unlock Free Earnings Estimates

Kura Sushi USA Earnings Reports

  • Kura Sushi USA | 10-Q: Q1 2025 Earnings Report

    Jan 7 16:24 ET

  • Kura Sushi USA | 8-K: Kura Sushi USA Announces Fiscal First Quarter 2025 Financial Results

    Jan 7 16:15 ET

  • Kura Sushi USA | 10-K: FY2024 Annual Report

    Nov 8, 2024 16:15 ET

  • Kura Sushi USA | 8-K: Kura Sushi USA Announces Fiscal Fourth Quarter and Fiscal Year 2024 Financial Results

    Nov 6, 2024 16:19 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Buy

    • Buy

      57.14%

    • Hold

      42.86%

    • Sell

      0.00%

    Price Target

    No Data